GSK and SK Bioscience start late-stage trial of Covid-19 vaccine

Subscribe
Get in touch

Before you go we'd just like to ask you a quick question!

Your vote has been counted in the results below.

If you could vote on Brexit now which option would you choose?
Remain Leave

GSK and SK Bioscience start late-stage trial of Covid-19 vaccine

GlaxoSmithKline (GSK) and South Korean pharmaceutical firm SK Bioscience have started a Phase 3 trial of their Covid-19 vaccine combination. GSK told the stock market on Tuesday that the advance follows “positive” interim results in the Phase 1 and 2 studies.

The Independent on MSN.com - August 31, 2021

View the full story here: https://www.msn.com/en-gb/finance/other/gsk-and-sk-bioscience-start-late-stage-trial-of-covid-19-vaccine/ar-AANVAcq

Contact Us

franklin@cccovid19.org
Our contact form
Curator login

Quick Links

Privacy policy
Terms & Conditions
Cookie Policies

© corona_virus 2026. All Right Reserved

Keep up to date with Connecting Communities for COVID19

Name*

Email*

Region*

Enter your region from the drop-down menu so we can tailor the news to you.

Privacy Policy | Terms & Conditions | Cookie Policies

Select or add an image to the Image library

Show only large

Search image library using the following tags

Cookie Notice - News Finder - corona_virus

We use cookies to enhance your visit to our site.
Read our Privacy policy, Cookie Policies and Terms & Conditions to find out more.